L. Lorand et al., NOVEL INHIBITORS AGAINST THE TRANSGLUTAMINASE-CATALYZED CROSS-LINKINGOF LENS PROTEINS, Experimental Eye Research, 66(5), 1998, pp. 531-536
Post-translational modifications by transglutaminase may contribute to
the remodeling of cellular architecture in the development of lens fi
ber cells, and there is evidence that the enzyme may also play a role
in cataract formation. It catalyses hydrolytic deamidations as well as
amide exchanges on select glutamine side chains at endo positions in
a small subset of proteins of the lens. N-epsilon(gamma-glutamyl)lysin
e crosslinks, the characteristic hallmarks of transglutaminase activit
y, were identified in polymers isolated from human cataract. Following
up on our earlier studies relating to the inhibition of protein cross
linking by the Ca2+-activated transglutaminase in the lens, we have no
w examined the effects of 2-[(2-oxopropyl)thio]imidazolium derivatives
, recently described as active site-directed inhibitors for this famil
y of enzymes. First, we have shown that the compounds at concentration
s of 1-2 mu M were effective in blocking the transamidating activities
of partially purified lens transglutaminase. Then we focused on their
efficacy in preventing the formation of the ca. 55 kDa beta crystalli
n dimers in the whole lens tissue. The production of these dimers, cro
sslinked by N-epsilon(gamma-glutamyl)lysine isopeptide bridges, is an
early sign of transglutaminase action in rabbit lens, and it can be re
adily documented by the SDS-PAGE analysis of proteins remaining in the
soluble phase after brief exposure of the homogenate to Ca2+. The new
compounds proved to be potent inhibitors of transglutaminase also in
this preparation, preventing the crosslinking event at ca. 1 mu M conc
entration. Moreover, even when applied at a 1,000-fold greater concent
ration (2 mM), they did not interfere with the action of calpain which
, similarly to the activation of the transglutaminase system, is trigg
ered by the addition of Ca2+. The high selectivity of the new compound
s for differentially blocking only the transglutaminase and not the ca
lpain of the lens, is all the more remarkable because these two enzyme
s share several mechanistic and structural similarities. (C) 1998 Acad
emic Press Limited.